These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 36167736)
1. Rehospitalization of Patients with Advanced Heart Failure Receiving Continuous, Palliative Dobutamine or Milrinone. Eaton RE; Kissling KT; Haas GJ; McLaughlin EM; Pickworth KK Am J Cardiol; 2022 Dec; 184():80-89. PubMed ID: 36167736 [TBL] [Abstract][Full Text] [Related]
2. Palliative Inotropes in Advanced Heart Failure: Comparing Outcomes Between Milrinone and Dobutamine. Sami F; Acharya P; Noonan G; Maurides S; Al-Masry AA; Bajwa S; Parimi N; Boda I; Tran C; Goyal A; Mastoris I; Dalia T; Sauer A; Bakel AV; Shah Z J Card Fail; 2022 Dec; 28(12):1683-1691. PubMed ID: 36122816 [TBL] [Abstract][Full Text] [Related]
3. Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Decompensated Heart Failure and Cardiogenic Shock. Biswas S; Malik AH; Bandyopadhyay D; Gupta R; Goel A; Briasoulis A; Fonarow GC; Lanier GM; Naidu SS Curr Probl Cardiol; 2023 Aug; 48(8):101245. PubMed ID: 35545181 [TBL] [Abstract][Full Text] [Related]
4. Comparison of Positive Inotropic Agents in the Management of Acute Decompensated Heart Failure. Kelly J; Cheng J; Malloy R; Lupi K J Cardiovasc Pharmacol; 2020 May; 75(5):455-459. PubMed ID: 32091426 [TBL] [Abstract][Full Text] [Related]
5. Effect of Inpatient Dobutamine versus Milrinone on Out-of-Hospital Mortality in Patients with Acute Decompensated Heart Failure. King JB; Shah RU; Sainski-Nguyen A; Biskupiak J; Munger MA; Bress AP Pharmacotherapy; 2017 Jun; 37(6):662-672. PubMed ID: 28475215 [TBL] [Abstract][Full Text] [Related]
6. Comparative Effectiveness and Safety of Intermittent, Repeated, or Continuous Use of Levosimendan, Milrinone, or Dobutamine in Patients With Advanced Heart Failure: A Network and Single-Arm Meta-analysis. Zhang X; Wang Z; Zhang L; Zhao X; Han Y J Cardiovasc Pharmacol; 2024 Jul; 84(1):92-100. PubMed ID: 38547524 [TBL] [Abstract][Full Text] [Related]
7. Survival With Continuous Outpatient Intravenous Inotrope Therapy in the Modern Era. Mody BP; Khan MH; Zaid S; Ahn C; Lloji A; Aronow WS; Gupta CA; Levine A; Gass AL; Cooper HA; Lanier GM Am J Ther; 2020 Oct; 28(6):e621-e630. PubMed ID: 33021537 [TBL] [Abstract][Full Text] [Related]
8. Need for hospice and palliative care services in patients with end-stage heart failure treated with intermittent infusion of inotropes. López-Candales AL; Carron C; Schwartz J Clin Cardiol; 2004 Jan; 27(1):23-8. PubMed ID: 14743852 [TBL] [Abstract][Full Text] [Related]
9. Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure. Gorodeski EZ; Chu EC; Reese JR; Shishehbor MH; Hsich E; Starling RC Circ Heart Fail; 2009 Jul; 2(4):320-4. PubMed ID: 19808355 [TBL] [Abstract][Full Text] [Related]
10. Intraoperative milrinone versus dobutamine in cardiac surgery patients: a retrospective cohort study on mortality. Nielsen DV; Torp-Pedersen C; Skals RK; Gerds TA; Karaliunaite Z; Jakobsen CJ Crit Care; 2018 Feb; 22(1):51. PubMed ID: 29482650 [TBL] [Abstract][Full Text] [Related]
11. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure. Arnold LM; Crouch MA; Carroll NV; Oinonen MJ Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484 [TBL] [Abstract][Full Text] [Related]
12. Inotropic therapy for right ventricular failure in newborn piglets: effect on contractility, hemodynamics, and interventricular interaction. Hyldebrandt JA; Frederiksen CA; Heiberg J; Rothmann S; Redington AN; Schmidt MR; Ravn HB Pediatr Crit Care Med; 2014 Sep; 15(7):e327-33. PubMed ID: 25080150 [TBL] [Abstract][Full Text] [Related]
13. Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial. Aranda JM; Schofield RS; Pauly DF; Cleeton TS; Walker TC; Monroe VS; Leach D; Lopez LM; Hill JA Am Heart J; 2003 Feb; 145(2):324-9. PubMed ID: 12595851 [TBL] [Abstract][Full Text] [Related]
14. Inotropes and cardiorenal syndrome in acute heart failure - A retrospective comparative analysis. Madeira M; Caetano F; Almeida I; Fernandes A; Reis L; Costa M; Gonçalves L Rev Port Cardiol; 2017 Sep; 36(9):619-625. PubMed ID: 28826934 [TBL] [Abstract][Full Text] [Related]
15. Continuous Cardiac Inotropes in Patients With End-Stage Heart Failure: An Evolving Experience. Malotte K; Saguros A; Groninger H J Pain Symptom Manage; 2018 Jan; 55(1):159-163. PubMed ID: 29030210 [TBL] [Abstract][Full Text] [Related]
16. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone. Barraud D; Faivre V; Damy T; Welschbillig S; Gayat E; Heymes C; Payen D; Shah AM; Mebazaa A Crit Care Med; 2007 May; 35(5):1376-82. PubMed ID: 17414729 [TBL] [Abstract][Full Text] [Related]
17. The effect of dobutamine vs milrinone in sepsis: A big data, real-world study. Zhu Y; Yin H; Zhang R; Ye X; Wei J Int J Clin Pract; 2021 Nov; 75(11):e14689. PubMed ID: 34331721 [TBL] [Abstract][Full Text] [Related]
18. Continuous Inotrope Therapy in Hospice Care: A Case Series. Patel K; D'Souza A; Groninger H Am J Hosp Palliat Care; 2019 Jul; 36(7):660-663. PubMed ID: 30630349 [TBL] [Abstract][Full Text] [Related]
19. Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact. Yamani MH; Haji SA; Starling RC; Kelly L; Albert N; Knack DL; Young JB Am Heart J; 2001 Dec; 142(6):998-1002. PubMed ID: 11717603 [TBL] [Abstract][Full Text] [Related]
20. Tolerability of beta-blockers in outpatients with refractory heart failure who were receiving continuous milrinone. Earl GL; Verbos-Kazanas MA; Fitzpatrick JM; Narula J Pharmacotherapy; 2007 May; 27(5):697-706. PubMed ID: 17461705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]